🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/06/1993 | 17,18 | 17,47 | 17,18 | 17,35 | +1,04% | 1,74% | 4.221.763 |
| 23/06/1993 | 17,12 | 17,29 | 17,06 | 17,18 | -0,69% | 1,39% | 4.506.190 |
| 22/06/1993 | 17,59 | 17,65 | 17,18 | 17,29 | -2,03% | 2,71% | 4.917.845 |
| 21/06/1993 | 17,77 | 17,83 | 17,59 | 17,65 | +0,00% | 1,34% | 2.966.888 |
| 18/06/1993 | 18,19 | 18,25 | 17,65 | 17,65 | -4,21% | 3,28% | 7.472.450 |
| 17/06/1993 | 18,37 | 18,55 | 18,31 | 18,43 | +0,33% | 1,30% | 3.251.106 |
| 16/06/1993 | 18,19 | 18,37 | 18,01 | 18,37 | +1,32% | 1,97% | 3.820.798 |
| 15/06/1993 | 18,55 | 18,55 | 18,07 | 18,13 | -2,56% | 2,57% | 3.962.278 |
| 14/06/1993 | 18,49 | 18,67 | 18,43 | 18,61 | +0,97% | 1,29% | 3.887.032 |
| 11/06/1993 | 18,13 | 18,43 | 18,01 | 18,43 | +2,66% | 2,30% | 4.223.440 |
| 10/06/1993 | 17,53 | 18,01 | 17,53 | 17,95 | +2,38% | 2,72% | 4.177.328 |
| 09/06/1993 | 17,47 | 17,65 | 17,35 | 17,53 | +0,69% | 1,71% | 2.978.416 |
| 08/06/1993 | 17,41 | 17,59 | 17,35 | 17,41 | -0,34% | 1,37% | 3.782.861 |
| 07/06/1993 | 17,53 | 17,59 | 17,35 | 17,47 | +0,00% | 1,36% | 3.219.875 |
| 04/06/1993 | 17,47 | 17,59 | 17,29 | 17,47 | -0,68% | 1,71% | 3.295.541 |
| 03/06/1993 | 17,59 | 17,83 | 17,53 | 17,59 | -1,01% | 1,69% | 3.486.067 |
| 02/06/1993 | 17,95 | 18,07 | 17,59 | 17,77 | -2,30% | 2,66% | 3.516.250 |
| 01/06/1993 | 18,31 | 18,31 | 18,13 | 18,19 | -0,33% | 0,98% | 3.605.958 |
| 28/05/1993 | 18,07 | 18,49 | 17,83 | 18,25 | +1,32% | 3,63% | 3.577.872 |
| 27/05/1993 | 18,67 | 18,79 | 17,95 | 18,01 | -3,21% | 4,47% | 4.156.997 |
| 26/05/1993 | 18,31 | 18,67 | 18,01 | 18,61 | +2,30% | 3,58% | 4.106.483 |
| 25/05/1993 | 18,19 | 18,31 | 18,07 | 18,19 | -0,65% | 1,31% | 2.447.499 |
| 24/05/1993 | 18,19 | 18,37 | 18,07 | 18,31 | +0,66% | 1,64% | 2.854.123 |
| 21/05/1993 | 18,43 | 18,67 | 18,19 | 18,19 | -2,56% | 2,59% | 5.515.414 |
| 20/05/1993 | 18,55 | 18,73 | 18,43 | 18,67 | +0,64% | 1,61% | 5.173.557 |
| 19/05/1993 | 18,43 | 18,61 | 18,19 | 18,55 | +1,30% | 2,27% | 6.404.118 |
| 18/05/1993 | 18,55 | 18,55 | 17,83 | 18,31 | -0,65% | 3,86% | 5.680.370 |
| 17/05/1993 | 18,25 | 18,55 | 17,89 | 18,43 | +3,34% | 3,59% | 6.487.539 |
| 14/05/1993 | 17,35 | 17,83 | 17,29 | 17,83 | +3,10% | 3,09% | 3.328.448 |
| 13/05/1993 | 17,24 | 17,47 | 17,06 | 17,29 | -1,36% | 2,42% | 3.960.392 |